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1. Materials and methods {#s0005}
========================

1.1. General {#s0010}
------------

^1^H-NMR and ^13^C-NMR spectra in CDCl~3~ or CD~3~OD with TMS as the internal standard were recorded using a JNM-GX-500 or Lambda 500 (JEOL, Tokyo, Japan) NMR spectrometer operating at 500 MHz and 125 MHz, respectively. 2D NMR data in CDCl~3~ were recorded using a Varian Inova 600 (Varian, Tokyo, Japan) NMR spectrometer operating at 600 MHz. Chemical shifts ($\delta$) were reported in parts per million (ppm) and the multiplicities were designated as follows: s (singlet), d (doublet), t (triplet), m (multiplet), dd (doublet of doublets), ddd (doublet of doublet of doublets), brd (broad doublet), t-like (triplet like), dt (doublet of triplets). The coupling constants (*J*) were reported in Hz. Fast atom bombardment (FAB) and high-resolution fast atom bombardment (HR-FAB) mass spectra were recorded with a JMS SX-102 (JEOL, Tokyo, Japan) spectrometer in positive ion mode using magic bullet (5:1 dithiothreitol/dithioerythritol; Tokyo Kasei Kogyo) or *m*-nitrobenzyl alcohol as the matrix. Infrared (IR) spectra were recorded by a diffusion-reflection method on KBr powder using an FT-IR-5300 (JASCO, Tokyo, Japan) spectrometer. Shoulder bands in the IR spectra were designated by sh. Optical rotations were measured in a 0.5 dm length cell with a DIP-370 (JASCO, Tokyo, Japan) digital polarimeter. For column chromatography, silica gel (Fuji Sylisia BW-200 or Merck 60--230 mesh) and octadecyl silane ODS (Cosmosil 75C~18~ OPN, Nacalai-Tesque) were used. Chemical reactions were performed under Ar gas unless otherwise indicated. TLC analyses were performed using normal-phase pre-coated plates (Kiesel gel 60F~254~, Merck) and reversed-phase high-performance thin-layer chromatography (HPTLC) plates (RP-18 WF~254S~, Merck). The spots on the thin-layer chromatograms were detected under UV light at 254 and 366 nm and visualized with either *p*-anisaldehyde/H~2~SO~4~ (5 mL of AcOH, 25 mL of *c*-H~2~SO~4~, 425 mL of EtOH, and 25 mL of water) or phosphomolybdic acid (5 g in 100 mL of EtOH) spraying reagents and subsequent heating.

1.2. Synthetic methods {#s0015}
----------------------

By following the synthetic routes described here below, we successfully synthesized four biotinylated probes of artemisinin that were used as molecular tools for the affinity labeling of *Trypanosoma brucei brucei* target proteins [@bib1].

### 1.2.1. Synthetic route to the biotinylated photoaffinity probe **2** {#s0020}

We first prepared the photoaffinity-labeling unit **6** according to the method described by Hatanaka et al. [@bib2; @bib3]. Direct condensation of **6** with dihydroartemisinin (**7**) (purchased from Tokyo Chemical Industry, Japan) using 1-\[3-(dimethylamino)propyl\]-3-ethylcarbodiimide hydrochloride (EDCI·HCl) and 4-(dimethylamino)pyridine (DMAP) in tetrahydrofuran afforded quantitatively probe **2** ([Scheme 1](#f0005){ref-type="fig"}).

*Preparation of probe **2**:* To a solution of **6** (26 mg, 0.043 mmol) in THF-CH~3~CN (1:1, 1.6 mL), were added dihydroartemisinin (**7**) (24.5 mg, 0.086 mmol), EDCI·HCl (24.8 mg, 3 mol equiv. to **6**), and DMAP (2.64 mg, 0.5 mol equiv. to **6**). The whole mixture was stirred at room temperature for 36 h. A crude mixture (108 mg) was obtained and applied to SiO~2~ column chromatography (CHCl~3~:CH~3~OH:H~2~O=7:3:1) yielding **2** (26 mg) quantitatively ([Scheme 1](#f0005){ref-type="fig"}).

Compound **2**: a white powder, \[$\alpha$\]~D~^25^ 162.4 (*c* 0.43, CHCl~3~), IR (KBr): 2926, 1740, 1695, 1610 cm^−1^, ^1^H NMR (CDCl~3~) $\delta$: 7.92 (1*H*, d, *J*=7.9 Hz, 6″-H), 6.81 (1*H*, d, *J*=7.9 Hz, 5″-H), 6.71 (1*H*, s, 3″-H), 5.96 (0.6*H*, d, *J*=9.7 Hz, 12β-H), 5.86 (0.4*H*, s, 12α-H), 5.49 (0.6*H*, s, 5-Ha), 5.43 (0.5*H*, s, 5-Hb), 4.48 (1*H*, m, 2′-H), 4.30 (1*H*, m, 3′-H), 4.19 (2*H*, t, *J*=4.9 Hz, 7″-H), 3.91 (2*H*, t, *J*=4.6 Hz, 14″-H), 3.42--3.76 (12*H*, m, 8″, 9″, 10″, 11″, 12″, 13″-H), 3.13 (1*H*, m, 1′-H), 2.88 (1*H*, dd, *J*=12.8, 5.5 Hz, 4′-Ha), 2.75 (1*H*, d, *J*=12.8 Hz, 4′-Hb), 2.55 (0.4*H*, m, 11-Hb), 2.37 (1*H*, ddd, *J*=4.3, 14.7, 14.7 Hz, 3α-H), 2.32 (2.6*H*, m, 11-Ha, 8′-H), 2.02 (1*H*, brd, *J*=*ca.* 14.5 Hz, 3β-H), 1.43 (3*H*, s, 14-H), 0.91--0.98 (6*H*, m, 13, 15-H). FAB-MS *m/z*: 892 \[M+Na\]^+^.

### 1.2.2. Synthetic route to the biotinylated photoaffinity probe **3** {#s0025}

Dihydroartemisinin (**7**) was condensed to ethylene glycol (**8**) under boron trifluoride-etherated catalysis in benzene, affording **9**. Condensation of **9** with **6** *via* the Yamaguchi reaction afforded the probe **3** in a 35% yield ([Scheme 2](#f0010){ref-type="fig"}).

*Preparation of **9** from **7**:* To a solution of **7** (200 mg, 0.704 mmol) in benzene (10 mL), were added ethylene glycol (**8**) (800 μL, 888 mg) (purchased from Wako, Japan) and 5% v/v BF~3~·Et~2~O in benzene (400 μL). The mixture was stirred for 2 h. Then, 5% v/v BF~3~·Et~2~O in benzene (400 μL) was added again, and an additional stirring of the mixture was performed for 3 h. The reaction was quenched with brine, extracted three times with EtOAc, dried over MgSO4, and evaporated under reduced pressure, affording a crude extract (287 mg). Subsequently, the crude was applied to SiO~2~ column chromatography (hexane:EtOAc=1:1) affording **9** (133.5 mg) in a 58% yield ([Scheme 2](#f0010){ref-type="fig"}).

*Preparation of probe **3** from **9**:* To a solution of **6** (5 mg, 0.007 mmol) in THF (0.2 mL) were added 2,4,6-trichlorobenzoyl chloride (1.1 μL, 1.7 mg, 0.9 mol equiv. to **6**) and Et~3~N (2.14 μL, 1.56 mg, 2 mol equiv. to **6**), and the entire mixture was stirred at room temperature overnight (*ca.* 15 h). Then, the previously prepared **9** (5.1 mg, 0.016 mmol) was added, and the mixture was stirred for 1 h at room temperature. Next, DMAP (0.47 mg, 0.5 mol equiv. to **6**) was added, and an additional stirring was performed overnight at room temperature. The reaction mixture was directly evaporated under reduced pressure, affording a crude product (18.2 mg) that was applied to SiO~2~ column chromatography (CHCl~3~:CH~3~OH:H~2~O=30:3:1→15:3:1) giving **3** (2.6 mg) in a 35% yield ([Scheme 2](#f0010){ref-type="fig"}).

Compound **3**: a white powder, \[$\alpha$\]~D~^25^ 145.2 (*c* 0.35, CHCl~3~), IR (KBr): 2934, 1735 (sh), 1699, 1613 cm^−1^, ^1^H NMR (CDCl~3~) $\delta$: 7.80 (1*H*, d, *J*=8.2 Hz, 6″-H), 6.81 (1*H*, d, *J*=8.2 Hz, 5″-H), 6.71 (1*H*, s, 3″-H), 5.36 (0.75*H*, s, 5-Ha), 5.33 (0.25*H*, s, 5-Hb), 4.83 (0.75*H*, d, *J*=3.7 Hz, 12α-H), 4.49 (2.25*H*, m, 12β-H, 2″′-Ha, 2′-H), 4.32 (1*H*, m, 3′-H), 4.19 (2*H*, t, *J*=5.1 Hz, 7″-H), 4.14 (1*H*, m, 2″′-Hb), 3.91 (2*H*, t, *J*=5.1 Hz, 14″-H), 3.43--3.77 (14*H*, m, 8″, 9″, 10″, 11″, 12″, 13″, 1″′-H), 3.13 (1*H*, ddd, *J*=5.5, 6.4, 6.4 Hz, 1′-H), 2.90 (1*H*, dd, *J*=12.8, 4.6 Hz, 4′-Ha), 2.72 (1*H*, d, *J*=12.8 Hz, 4′-Hb), 2.61 (0.75*H*, m, 11-Ha), 2.45 (0.25*H*, m, 11-Hb), 2.37 (1*H*, ddd, *J*=3.7, 14.6, 14.6 Hz, 3α-H), 2.21 (2*H*, m, 8′-H), 2.02 (1*H*, brd, *J*=*ca.*14 Hz, 3β-H), 1.43 (0.75*H*, s, 14-Hb), 1.42 (2.25*H*, s, 14-Ha), 0.96 (0.75*H*, d, *J*=5.4 Hz, 15-Hb), 0.88 (2.25*H*, d, *J*=7.4 Hz, 13-Ha), 0.86 (0.75*H*, d, *J*=7.4 Hz, 13-Hb), 0.83 (2.25*H*, d, *J*=5.5 Hz, 15-Ha).

### 1.2.3. Synthetic route to the biotinylated photoaffinity probe **4** {#s0030}

We began the process with γ-butyrolactone (**10**) that underwent methanolysis in the first step, followed by protection of the primary alcohol with *tert*-butyldimethylsilyl chloride (TBSCl) in dichloromethane in the second step, affording **11**, which was hydrolyzed under basic conditions to yield the *tert*-butyldimethylsilyl (TBS)-ether carboxylic acid **12**. Condensation of **12** with **7** under EDCI·HCl and DMAP in tetrahydrofuran (THF) led to **13**, which was deprotected using a Dowex cation resin (50WX8, 100-200 mesh, H Cation Exchange Resin, Sigma-Aldrich) in MeOH, affording **14**. Finally, condensation of **14** with **6** using EDCI·HCl and DMAP in THF afforded probe **4** in a 28% yield ([Scheme 3](#f0015){ref-type="fig"}).

*Preparation of **13** from **12**:* To a solution of **12** (19 mg, 0.087 mmol) in THF (1.2 mL) were added **7** (6.2 mg, 0.022 mmol), EDCI·HCl (31.68 mg, 2 mol equiv. to **12**), and DMAP (5.30 mg, 0.5 mol equiv. to **12**). The mixture was stirred at room temperature for 2 h. Then, EDCI·HCl (31.68 mg) and DMAP (5.30 mg) were added again, and an additional stirring was performed for 2 h. Following a reaction work up with brine, the mixture was extracted with EtOAc. The EtOAc layer was washed once with 5% HCl, once with saturated aqueous NaHCO~3~, once with brine, and then dried over MgSO4. Subsequent evaporation under reduced pressure produced **13** (18 mg) quantitatively ([Scheme 3](#f0015){ref-type="fig"}).

Compound **13**: a white powder, \[$\alpha$\]~D~^25^ 148.3 (*c* 0.40, CHCl~3~), IR (KBr): 2928, 1750 cm^−1^, ^1^H NMR (CDCl~3~) $\delta$: 5.81 (α, d, *J*=9.7 Hz, 12β-H), 5.44 (1*H*, s, 5-H), 3.89 (2*H*, t, *J*=6.4 Hz, 3′-H), 2.55 (1*H*, m, 11-H), 2.53 (1*H*, t, *J*=6.4 Hz, 1′-H), 2.34 (1*H*, ddd, *J*=3.7, 14.3, 14.4 Hz, 3α-H), 2.04 (1*H*, brd, *J*=*ca.*13 Hz, 3β-H), 1.43 (3*H*, s, 14-H), 0.96 (3*H*, d, *J*=6.1 Hz, 15-H), 0.84 (3*H*, d, *J*=7.4 Hz, 13-H).

*Preparation of probe **4** from **14**:* To a solution of **6** (0.7 mg, 0.001 mmol) in THF-CH~3~CN (1:1, 90 μL) were added the previously prepared **14** (0.8 mg, 0.002 mmol), EDCI·HCl (0.63 mg, 3 mol equiv. to **6**), and DMAP (0.07 mg, 0.5 mol equiv. to **6**), and then the mixture was stirred at room temperature for 3 h. Then, EDCI·HCl (0.63 mg) and DMAP (0.07 mg) were added, and an additional stirring was performed at room temperature for 30 min, followed by another stirring performed at 40 °C for 2 h. Subsequently, the reaction mixture was evaporated under reduced pressure, affording a crude product (4.2 mg) that was applied to SiO~2~ column chromatography (CHCl~3~:CH~3~OH:H~2~O=10:3:1→benzene: acetone=1:1 →1:2) giving **4** (0.3 mg) in a 28% yield ([Scheme 3](#f0015){ref-type="fig"}).

Compound **4**: a white powder, \[$\alpha$\]~D~^25^ 158.8 (*c* 0.45, CHCl~3~), IR (KBr): 2930, 1735 (sh), 1698, 1608 cm^−1^, ^1^H NMR (CDCl~3~) $\delta$: 7.79 (1*H*, d, *J*=8.5 Hz, 6″-H), 6.82 (1*H*, d, *J*=8.5 Hz, 5″-H), 6.71 (1*H*, s, 3″-H), 5.97 (1*H*, d, *J*=9.8 Hz, 12β-H), 5.49 (1*H*, s, 5-H), 4.94 (2*H*, t-like, *J*=*ca.* 5 Hz, 3″′-H), 4.51 (1*H*, m, 2′-H), 4.32 (1*H*, m, 3′-H), 4.20 (2*H*, m, 7″-H), 3.90 (2*H*, m, 14″-H), 3.42--3.76 (12*H*, m, 8″, 9″, 10″, 11″, 12″, 13″-H), 3.13 (1*H*, ddd, *J*=4.9, 7.3, 7.3 Hz, 1′-H), 2.92 (1*H*, dd, *J*=12.8, 4.9 Hz, 4′-Ha), 2.72 (2*H*, m, 1″′-Ha, 4′-Hb), 2.56 (1*H*, m, 11-H), 2.34 (2*H*, m, 3α-H, 1″′-Hb), 2.21 (2*H*, m, 8′-H), 2.02 (1*H*, brd, *J*=*ca.* 14 Hz, 3β-H), 1.41 (3*H*, s, 14-H), 0.98, 0.92 (both 3*H*, d, *J*=6.1, 7.3 Hz, 15-H, 13-H).

### 1.2.4. Synthetic route to the biotinylated affinity probe **5** {#s0035}

We started with [d]{.smallcaps}-biotin (**15**) that underwent a Curtius rearrangement in the first step, followed by condensation with tetraethylene glycol (**16**) in the second step to afford **17**, which underwent a Michael addition to **18** and then hydrolyzed under basic conditions to afford the affinity labeling unit **19**. Condensation of **19** with **7** using EDCI·HCl and DMAP in THF-CH~3~CN=1:1 afforded probe **5** in a 68% yield ([Scheme 4](#f0020){ref-type="fig"}).

*Preparation of **19** from **17**:* To a solution of **17** (6.3 mg, 0.0145 mmol) in CH~2~Cl~2~ (144 μL) cooled to 0 °C were added NaH (588 μg, 1.0 mol equiv. to **17**) and **18** (6.5 μL, 6.2 mg, 5.0 mol equiv. to **17**). The reaction mixture was stirred at 0 °C for 1 h, which was then worked up with saturated aqueous NH~4~Cl until neutral pH. Following evaporation under reduced pressure, a crude product (22 mg) was obtained and subsequently applied to SiO~2~ column chromatography (CHCl~3~:CH~3~OH=18:1), affording the methyl ester derivative **19′** (6.7 mg) in an 88% yield. Then, in the second step, to a solution of **19′** (6.7 mg, 0.013 mmol) in MeOH (150 μL) was added 150 μL of 6 N aqueous NaOH. The reaction mixture was stirred at 40 °C for 15 min. Then, Dowex cation resin (50WX8, 100-200 mesh, H Cation Exchange Resin, Sigma-Aldrich) was added until neutral pH. Following filtration over a cotton pad, the mixture was evaporated under reduced pressure. The afforded crude product (6.9 mg) was applied to SiO~2~ column chromatography (CHCl~3~:CH~3~OH:H~2~O=15:3:1), giving **19** (4 mg) in a 68% yield ([Scheme 4](#f0020){ref-type="fig"}).

Compound **19**: a white powder, \[$\alpha$\]~D~^25^ 24.2 (*c* 0.33, CHCl~3~), IR (KBr): 3296, 2928, 1703 cm^−1^, ^1^H NMR (CDCl~3~) $\delta$: 4.51 (1*H*, m, 2-H), 4.34 (1*H*, m, 3-H), 4.23 (2*H*, t, *J*=4.9 Hz, 10′-H), 3.74 (2*H*, t, *J*=6.1 Hz, 2″-H), 3.61--3.70 (14*H*, m, 3′, 4′, 5′, 6′, 7′, 8′, 9′-H), 3.23 (1*H*, m, 1-H), 3.13 (2*H*, m, 8-H), 2.90 (1*H*, brd, *J*=*ca.*12 Hz, 4-Ha), 2.73 (1*H*, d, *J*=12.2 Hz, 4-Hb), 2.61 (2*H*, t, *J*=6.1 Hz, 1′-H).

*Preparation of the probe **5** from **19**:* To a solution of **19** (4 mg, 0.008 mmol) in THF-CH~3~CN (1:1, 500 μL) were added **7** (4.78 mg, 0.0168 mmol), EDCI·HCl (4.83 mg, 3 mol equiv. to **19**), and DMAP (0.52 mg, 0.5 mol equiv. to **19**), and then the mixture was stirred at room temperature for 6 h. Following subsequent evaporation under reduced pressure, the crude product (17.7 mg) was applied to SiO~2~ column chromatography (CHCl~3~:CH~3~OH:H~2~O=10:3:1→benzene:acetone=1:2→100% MeOH), giving **5** (4.3 mg) in a 68% yield ([Scheme 4](#f0020){ref-type="fig"}).

Compound **5**: a white powder, \[$\alpha$\]~D~^25^ 164.9 (*c* 0.46, CHCl~3~), IR (KBr): 2928, 1740 (sh), 1703 cm^−1^, ^1^H NMR (CDCl~3~) $\delta$: 5.79 (1*H*, d, *J*=9.8 Hz, 12β-H), 5.44 (1*H*, s, 5-H), 4.51 (1*H*, dd, *J*=7.7, 5.1 Hz, 2′-H), 4.35 (1*H*, dd, *J*=7.7, 4.6 Hz, 3′-H), 4.20 (2*H*, m, 10″-H), 3.76 (2*H*, dd, *J*=6.6, 6.5 Hz, 2″-H), 3.62--3.69 (14*H*, m, 3″, 4″, 5″, 6″, 7″, 8″, 9″-H), 3.15 (3*H*, m, 1′, 8′-H), 2.90 (1*H*, dd, *J*=4.6, 12.6 Hz, 4′-Ha), 2.74 (1*H*, d, *J*=12.6 Hz, 4′-Hb), 2.69 (2*H*, dt, *J*=12.8, 6.6 Hz, 1″-Ha), 2.60 (2*H*, dt, *J*=12.8, 6.5 Hz, 1″-Hb), 2.55 (1*H*, m, 11-H), 2.37 (1*H*, dt, *J*=3.9, 13.7 Hz, 3α-H), 2.03 (1*H*, brd, *J*=*ca.*14 Hz, 3β-H), 1.43 (3*H*, s, 14-H), 0.96 (3*H*, d, *J*=5.9 Hz, 15-H), 0.84 (3*H*, d, *J*=7.1 Hz, 13-H). FAB-MS *m/z*: 774 \[M+H\]^+^.
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